Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Leukemia & Lymphoma
|
May 20, 2009
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same
Amir A Toor
Immunological Investigations
|
October 9, 2014
Etiology of GVHD: alloreactivity or impaired cellular adaptation?
Masoud H Manjili, Amir A Toor
Bone Marrow Transplantation
|
October 26, 2022
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis
Ghada ElGohary, Amir A Toor, Usama Gergis
British Journal of Haematology
|
September 9, 2004
Post-transplant air-leak syndrome
Tawee Tanvetyanon, Amir A Toor, Patrick J Stiff
Journal of the Royal Society, Interface
|
January 15, 2016
On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments
Amir A Toor, Abdullah A Toor, Mohamed Rahmani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2003
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective
Julian P Cooney, Patrick J Stiff, Amir A Toor, et al.
Clinical & Developmental Immunology
|
October 26, 2012
Immunotherapy of cancer: reprogramming tumor-immune crosstalk
Kyle K Payne, Amir A Toor, Xiang-Yang Wang, et al.
Bone Marrow Transplantation
|
September 2, 2018
A dynamical systems perspective on chimeric antigen receptor T-cell dosing
Amir A Toor, Alden Chesney, Jamal Zweit, et al.
European Journal of Haematology
|
May 30, 2019
Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid
Ariel Sindel, Trevor Taylor, Alden Chesney, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 2, 2021
High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation
Kelly G Hawks, Amanda Fegley, Roy T Sabo, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Leukemia & Lymphoma
|
May 20, 2009
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same
Amir A Toor
Immunological Investigations
|
October 9, 2014
Etiology of GVHD: alloreactivity or impaired cellular adaptation?
Masoud H Manjili, Amir A Toor
Bone Marrow Transplantation
|
October 26, 2022
Engraftment syndrome after allogeneic stem cell transplantation: a systematic review and meta-analysis
Ghada ElGohary, Amir A Toor, Usama Gergis
British Journal of Haematology
|
September 9, 2004
Post-transplant air-leak syndrome
Tawee Tanvetyanon, Amir A Toor, Patrick J Stiff
Journal of the Royal Society, Interface
|
January 15, 2016
On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments
Amir A Toor, Abdullah A Toor, Mohamed Rahmani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2003
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective
Julian P Cooney, Patrick J Stiff, Amir A Toor, et al.
Clinical & Developmental Immunology
|
October 26, 2012
Immunotherapy of cancer: reprogramming tumor-immune crosstalk
Kyle K Payne, Amir A Toor, Xiang-Yang Wang, et al.
Bone Marrow Transplantation
|
September 2, 2018
A dynamical systems perspective on chimeric antigen receptor T-cell dosing
Amir A Toor, Alden Chesney, Jamal Zweit, et al.
European Journal of Haematology
|
May 30, 2019
Hematopoietic stem cell mobilization following PD-1 blockade: Cytokine release syndrome after transplantation managed with ascorbic acid
Ariel Sindel, Trevor Taylor, Alden Chesney, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
December 2, 2021
High dose valacyclovir for cytomegalovirus prophylaxis following allogeneic hematopoietic cell transplantation
Kelly G Hawks, Amanda Fegley, Roy T Sabo, et al.
Page
of 4